The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rizvi Qasim since 2021.
This trader's CIK number is 1794636.
At the time of last reporting, Rizvi Qasim was the Chief Commercial Officer of Kiniksa Pharmaceuticals, Ltd.. (stock ticker symbol KNSA).
Also see all insider trading activities at Kiniksa Pharmaceuticals, Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | KNSA | 0 | $0 | 0 | $0 | 7,337 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-31 | KNSA | Option Ex | 7,337 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rizvi Qasim (Chief Commercial Officer of Kiniksa Pharmaceuticals, Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.